the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children - Trial NCT01919203
Access comprehensive clinical trial information for NCT01919203 through Pure Global AI's free database. This phase not specified trial is sponsored by Sangjin Park and is currently Completed. The study focuses on Respiratory Complication. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sangjin Park
Yeungnam University College of Medicine
Timeline & Enrollment
N/A
Aug 01, 2013
Jul 01, 2015
Primary Outcome
patients's response to the LMA insertion
Summary
This research attempts to find the optimum dose of remifentanil that can prevent the
 unnecessary responses such as coughing, gagging, and movement when LMA is inserted during
 sevoflurane induction in pediatric patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01919203
Non-Device Trial